Duality Biotherapeutics Chairman’s Shareholding Increase Expected to Reach Up to $10 Million
Duality Biotherapeutics says the total increase in its chairman’s shareholding is expected to be up to $10 million.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Duality Biotherapeutics says the total increase in its chairman’s shareholding is expected to be up to $10 million.
Duality Biotherapeutics said its chairman’s total shareholding increase is expected to be up to $10 million.